CoChat

Exploring pathways for memory T cell generation

Open access
Sallusto, Federica, Lanzavecchia, Antonio · 2001 · Journal of Clinical Investigation
Cited by 108

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Upon primary immunization, antigen-specific T cells proliferate, generating a large number of effector cells that migrate to peripheral tissues to fight pathogens. Some of these primed T cells develop into memory cells, which confer immediate protection as well as the capacity to mount a more rapid and effective secondary immune response. Understanding the multiple facets of immunological memory and its relationship to protection remains a central issue in immunology (1, 2). Memory T cells have been traditionally viewed as survivors of effector cells that revert to a quiescent state (Figure ​(Figure1a).1a). However, memory T cells have been shown to be heterogenous and to comprise at least two subsets, endowed with different migratory capacity and effector function (3–5). Cells of the first subset resemble the effector cells generated in the primary response in that they lack the lymph node–homing receptors L-selectin and CCR7 and express receptors for migration into inflamed tissues. Upon re-encounter with antigen, these “effector memory T cells” (TEM) can rapidly produce IFN-γ or IL-4 or release pre-stored perforin. Cells of the second subset express L-selectin and CCR7 as naive T cells and lack immediate effector function. These “central memory T cells” (TCM) have a low activation threshold and, upon restimulation in secondary lymphoid organs, proliferate and differentiate to effectors (6). Figure 1 Pathways for memory T cell generation. (a) According to the most conventional model, memory T cells are derived from effector cells that revert to a quiescent state. (b) According to the new model of progressive T cell differentiation, the duration of ... An outstanding question with broad basic and practical implication relates to the signals that drive the formation of the two types of memory T cells. In this issue of the JCI, Manjunath et al. show that cytokines can modulate the differentiation of CD8+ T cells (7). Taking advantage of an earlier serendipitous discovery — that a green fluorescent protein reporter gene (T-GFP) is expressed in naive and short-term activated T cells is silent in terminally differentiated effector cells (8) — the authors have defined conditions for the expansion of almost pure populations of TCM or TEM (7). In these transgenic mice GFP expression can be conveniently used to monitor T cell differentiation. Now, Manjunath et al. have generated naive T cells from T-GFP mice carrying a class I–restricted T cell receptor (TCR) that recognizes a specific viral peptide (7). They stimulated these cells in vitro with antigen for 2 days and expanded them in the presence of different cytokines. When cultured in high doses of IL-2 (CD8IL-2), the cells become large blasts, express high levels of activation markers, lose expression of GFP and the chemokine receptor CCR7, and acquire the capacity to produce IFN-γ and to kill target cells. In contrast, the same cells cultured in the presence of IL-15 (CD8IL-15), or of low doses of IL-2, become small, retain GFP and CCR7 expression, and fail to acquire cytotoxic function, although they acquire IFN-γ–producing capacity. Importantly, after adoptive transfer, CD8IL-15 cells survive for several weeks and, upon antigen rechallenge, mount a secondary response that is comparable to that mediated by endogenously generated memory cells. The migratory properties of CD8IL-2 and CD8IL-5 are described in an elegant study by the same group, now in press in The Journal of Experimental Medicine (9). This study shows that central memory-like CD8IL-15 cells home avidly to lymphoid organs, where they mediate rapid recall responses; these cells are only moderately efficient at homing to sites of inflammation. Conversely, CD8IL-2 effector-like T cells accumulate in inflamed tissues but are excluded from lymph nodes and Peyer’s patches. Together the two papers (7, 9) indicate that the amount and quality of cytokines can precisely determine the differentiation of CD8+ T cells, altering their effector function and their migratory capacity. Whereas high doses of IL-2 drive terminal differentiation to tissue-homing effector cells, IL-15 preserves the proliferating cells’ ability to home to lymph nodes and maintains the cells in an intermediate state of differentiation characteristic of central memory cells. Studies on CD4+ T cells have previously supported the model of progressive T cell differentiation shown in Figure ​Figure1b1b (10). For CD4+ T cells the differentiation process is controlled by the interplay between duration of TCR stimulation and cytokines. Thus, while a prolonged TCR stimulation in the presence of IL-12 or IL-4 promotes terminal differentiation to effector Th1 or Th2 cells respectively, a short TCR stimulation and TGF-β preserve the cells in a central memory-like stage (6, 11–13). Thus, the above studies, together with that of Manjunath et al. (7), point to the same conclusion, namely that for both CD4+ and CD8+ T cells

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci14005

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 108

Metadata

Authors
Sallusto, F., & Lanzavecchia, A.
Venue
Journal of Clinical Investigation
Published
2001-09-15
Volume
108
Issue
6
Pages
805-806
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2087867391
Cited by
108
References
4
FWCI
2.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploring pathways for memory T cell generation. https://app.cochat.ai/papers/10.1172/jci14005
The paper
Sallusto, F., & Lanzavecchia, A. (2001). Exploring pathways for memory T cell generation. Journal of Clinical Investigation. https://doi.org/10.1172/jci14005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.